el-Harazi, S M <br/><br/>
A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.  [electronic resource] 

 -  Ophthalmic surgery and lasers  Jul 1998 
 - 539-44 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1082-3069 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Inflammatory Agents--administration & dosage<br/>Anti-Inflammatory Agents, Non-Steroidal--administration & dosage<br/>Cell Count<br/>Diclofenac--administration & dosage<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Intraocular Pressure--drug effects<br/>Ketorolac Tromethamine<br/>Lens Implantation, Intraocular<br/>Male<br/>Middle Aged<br/>Ophthalmic Solutions<br/>Phacoemulsification--adverse effects<br/>Postoperative Complications--prevention & control<br/>Prednisolone--administration & dosage<br/>Safety<br/>Tolmetin--administration & dosage<br/>Tromethamine--administration & dosage<br/>Uveitis, Anterior--etiology